Jean Guibourdenche

ORCID: 0000-0003-3968-6890 · 5 papers in corpus · active 2010-2025

Study types

  • article 3
  • other 2

Condition tags

  • endometriosis 4
  • die_deep_infiltrating 4
  • mesh:D004715 3
  • infertility 2
  • adenomyosis 2
other 2025
Reply: Fetal safety of dydrogesterone: clarifying the role of pharmacovigilance
Human reproduction open ·doi:10.1093/hropen/hoaf031
article 2024
O-146 Serum Progesterone levels do not differ between patients with endometriosis and unaffected patients who conceive after Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) cycles
·doi:10.1093/humrep/deae108.165

Abstract Study question Do endometriosis women who achieve a live birth (LB) after Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) have different transfer-day progesterone levels than controls? Summary answer In women achieving…

article 2024
Progesterone levels do not differ between patients with or without endometriosis/adenomyosis both in those who conceive after hormone replacement therapy-frozen embryo transfer cycles and those who do not
Human Reproduction ·doi:10.1093/humrep/deae114

STUDY QUESTION: Do women with endometriosis who achieve a live birth (LB) after HRT-frozen embryo transfer (HRT-FET) have different progesterone levels on the day of transfer compared to unaffected women? SUMMARY ANSWER: In women achieving …

article 2011
The mTOR/AKT Inhibitor Temsirolimus Prevents Deep Infiltrating Endometriosis in Mice
The American journal of pathology ·doi:10.1016/j.ajpath.2011.04.020
other 2010
Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis
The American journal of pathology ·doi:10.2353/ajpath.2010.100375

Deep infiltrating endometriosis (DIE) is characterized by chronic pain, hyperproliferation of endometriotic cells and fibrosis. Since cannabinoids are endowed with antiproliferative and antifibrotic properties, in addition to their psychoge…